Tianjin Bogene Technology Co Ltd

The safety, pharmacokinetic behavior and immunogenicity of JZB30 and GONAL-F in healthy adult female subjects in China were evaluated through a single-center, randomized, open-label, two-period, crossover, single subcutaneous injection bioequivalence trial to provide a reference for rational clinical drug use.

Primary objective: To evaluate the effectiveness of JZB30 and GONAL-F in Chinese women undergoing controlled ovarian stimulation and ovulation induction for assisted reproductive technology (ART) Secondary objective: To evaluate the safety and immunogenicity of JZB30 and GONAL-F in Chinese women undergoing controlled ovarian stimulation and ovulation induction for assisted reproductive technology (ART)